Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Guadalajara
Clinical trial register · Mexico

Clinical Trials in Guadalajara, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:18 UTC
1585
Studies in scope
all four open statuses
715
Recruiting now
open to new participants
254
Lead sponsors
across recruiting studies
Top sites
Mexico City 17 Monterrey 15 Guadalajara 14 Mérida 8 Chihuahua City 8
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Guadalajara

14 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Guadalajara, Cuauhtémoc, Chihuahua City
2025-01-31
Recruiting
Novartis Pharmaceuticals
Phase 2
200
Chihuahua City, Guadalajara, Mexico City, Monterrey
2024-10-09
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Guadalajara
2024-06-28
Recruiting
Novartis Pharmaceuticals
Phase 3
550
León, Guadalajara, Mexico City, Morelia, Mérida, México
2024-05-21
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Guadalajara, Cuauhtémoc, Villahermosa, Mérida
2023-11-15
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Guadalajara, Mexico City, Culiacán, Mérida, México
2023-10-27
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Guadalajara, San Juan del Río, Villahermosa, Querétaro
2023-05-11
Active, closed
Novartis Pharmaceuticals
Phase 3
288
León, Guadalajara, Mexico City, Morelia, Mérida, México
2023-04-21
Active, closed
Novartis Pharmaceuticals
Phase 4
240
Chihuahua City, Guadalajara, Mérida
2023-03-28
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
León, Actopan, Guadalajara, Gustavo Adolfo Madero, Mexico City, Tlalpan, Cuernavaca, Monterrey
2023-03-09
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Guadalajara, San Pedro G G, Veracruz
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Guadalajara, Mexico City, Monterrey, Tlalnepantla, Mérida, Acapulco, Aguascalientes, Chihuahua City
2021-11-23
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
Novartis Pharmaceuticals
Phase 4
1,000
Guadalajara, Culiacan, Metepec
2020-12-22
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-mexico/city/guadalajara

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 12 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Guadalajara that also match the filters currently applied.

How many clinical trials are recruiting in Guadalajara?

4 of the 14 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Guadalajara), 14 studies
PhaseStudiesRecruitingShare
Phase 311278.6%
Phase 42114.3%
Phase 2117.1%

Most active sponsors

Lead sponsors with the most studies (Guadalajara)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals144
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.